Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage…
InnovAge Florida PACE Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”)…
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq:…
Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements
Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq:…
Smart Share Global Limited Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company from Hillhouse
August 15, 2025 16:15 ET | Source: Smart Share Global Limited SHANGHAI,…
Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results
NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings…
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer…
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc.,…
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)
August 15, 2025 16:05 ET | Source: X4 Pharmaceuticals BOSTON, Aug. 15,…
Automobili Lamborghini Unveils Fenomeno, a New Limited Production Masterpiece at The Quail, A Motorsports Gathering
Produced in just 29 units, the Fenomeno is the most powerful V12…
